10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference
Rhea-AI Summary
10x Genomics (Nasdaq: TXG) said its management team will take part in a fireside chat at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13, 2026 at 5:00 p.m. Pacific Time.
The event will be webcast live via the Investors section of the company website and archived for replay for at least 30 days.
Positive
- None.
Negative
- None.
News Market Reaction – TXG
In the Apr 30 session, TXG gained 9.16%, reflecting a notable positive market reaction. Argus tracked a peak move of +11.8% during that session. Our momentum scanner triggered 50 alerts that day, indicating high trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 18 | Product platform launch | Positive | -5.7% | Introduced Atera in situ spatial biology platform with pre-orders and 2H26 shipments. |
| Apr 15 | Earnings call scheduling | Neutral | -0.4% | Announced date and time for Q1 2026 financial results and webcast details. |
| Mar 25 | Partnership ecosystem news | Positive | +5.5% | Bioptimus STELA atlas launch highlighting 10x Genomics as a key spatial biology partner. |
| Mar 17 | Platform data showcase | Positive | +8.4% | PerturbAI unveiled large in vivo CRISPR atlas generated with 10x technologies. |
| Feb 19 | Conference participation | Neutral | -1.6% | Announced fireside chat at TD Cowen healthcare conference with webcast access. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent product and partnership news often saw aligned positive reactions, while the Atera launch drew a negative move, showing occasional sell-the-news behavior. Conference participation headlines have previously coincided with modest declines.
Over the last few months, TXG has reported several notable developments. On Feb 19, management announced participation in the TD Cowen healthcare conference with a small share price decline. Positive ecosystem news on Mar 17 and Mar 25 around large-scale CRISPR and spatial biology atlases coincided with gains of 8.39% and 5.55%. However, the Apr 18 launch of the Atera platform led to a -5.71% move, indicating some profit-taking or cautious reception. Today’s BofA conference participation fits the pattern of neutral, investor-relations-focused updates.
Key Terms
spatial biology medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X, Facebook, Bluesky or YouTube.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-participate-in-the-bofa-securities-2026-healthcare-conference-302757611.html
SOURCE 10x Genomics, Inc.